RedHill Biopharma RDHL
NASDAQ RDHL
$0.69 +0.03 (+4.56%)
As of: Sep 9, 2026 · 3:26 PM EDT

RedHill Biopharma (RDHL) Property, Plant & Equipment (Net) (2011 - 2025)

Analysis

RedHill Biopharma (RDHL) Property, Plant & Equipment (Net) (2011 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Teva Pharmaceutical Industries 42.72 Bn 39.07 Bn 2.15 Bn 3.93 Bn
2 Viatris 19.14 Bn 18.26 Bn 1.46 Bn 2.44 Bn
3 Dr Reddys Laboratories 9.89 Bn 9.71 Bn 396.53 Mn 1.22 Bn
4 Amneal Pharmaceuticals 5.46 Bn 5.34 Bn 334.51 Mn 456.88 Mn
5 Bausch Health Companies 2.33 Bn 494.50 Mn 2.10 Bn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 381.58 Mn
7 Ani Pharmaceuticals 1.48 Bn 1.12 Bn 165.89 Mn 73.22 Mn
8 Amphastar Pharmaceuticals 994.43 Mn 704.31 Mn 93.47 Mn 389.13 Mn
9 Fennec Pharmaceuticals 399.34 Mn 358.09 Mn 17.15 Mn -
10 RedHill Biopharma 178.33 Mn 178.33 Mn - 49,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 49,000.00
Jun 30, 2025 126,000.00
Dec 31, 2024 135,000.00
Jun 30, 2024 147,000.00
Dec 31, 2023 193,000.00
Jun 30, 2023 244,000.00
Mar 31, 2023 444,000.00
Dec 31, 2022 502,000.00
Sep 30, 2022 568,000.00
Jun 30, 2022 616,000.00
Mar 31, 2022 528,000.00
Dec 31, 2021 572,000.00
Sep 30, 2021 477,000.00
Jun 30, 2021 506,000.00
Mar 31, 2021 553,000.00
Dec 31, 2020 511,000.00
Sep 30, 2020 473,000.00
Jun 30, 2020 345,000.00
Mar 31, 2020 360,000.00
Dec 31, 2019 228,000.00